Product Decisions & Trade-offs

Product Decisions & Trade-offs is an intermediate product decision-making course built around the choices PMs face when the data is incomplete, stakeholders disagree, and familiar prioritisation frameworks do not produce an answer. Paulo Garcia organises the material into three levels—tactical decisions, business and strategic thinking, and leadership under pressure—so the course connects everyday execution with the larger bets that become more important as your scope grows. It is fully online, self-paced, interactive, and designed to take about three hours.

The tactical level covers mental models for reversible and irreversible decisions, evidence quality, prioritisation, sequencing, flow, and the cost of delay. Rather than treating discovery evidence as equally reliable, you learn to match the fidelity of an experiment to the risk of the decision. The business level moves from backlog ranking to investment choices. Lessons address B2B, B2C, and product-led business models, business cases using metrics such as lifetime value and churn, resource allocation across a portfolio, and the complete product lifecycle—including deprecation and sunsetting. The leadership level adds stakeholder mapping, pre-wiring, ethical product decisions, cognitive bias, decision quality, and leading teams through restructuring or declining performance.

The course is useful for product managers who already understand basic discovery, roadmapping, and cross-functional work. Associate PMs can use it to build a more deliberate decision process, while senior, principal, and lead PMs will find material on portfolio bets, organisational influence, and crisis leadership. Ten lessons, three level tests, and short exercises make the content easy to fit into a working week. The first level can be tried free; full access and the certificate require a Uxcel Pro or Teams membership.

What makes this course distinctive is its range. Many prioritisation courses end once features have been scored. This one follows decisions through financial reasoning, portfolio allocation, stakeholder dynamics, ethics, and the uncomfortable work of stopping a product or communicating bad news. You finish with a broader set of questions to ask: Is the choice reversible? What evidence matches the downside? What is the cost of waiting? Which assumption drives the business case? Who needs to be involved before the meeting? The result is not automatic certainty, but a more transparent and defensible way to make trade-offs.